Recursion Pharmaceuticals, Inc.

daily support level, mean reversion rebound

374
daily supp level

nvda earnings in AH

price action speaks itself, upside break of trendline and lower vwap band, H&S

mean reversion rebound play with huge potential to be runners if RXRX decide to breakout of its current trading range

bad news overpriced while merger news' full implication on price has yet to be captured

no at bad price to stock up

etc

What do you think?
노트
wait for sustained upside break of trendline and lower vwap band to signal entry, else no entry

면책사항

이 정보와 게시물은 TradingView에서 제공하거나 보증하는 금융, 투자, 거래 또는 기타 유형의 조언이나 권고 사항을 의미하거나 구성하지 않습니다. 자세한 내용은 이용 약관을 참고하세요.